Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mogamulizumab and the Treatment of Ccr4-Positive T-Cell Lymphomas
Marcus Remer, Aymen Al‐Shamkhani, Martin J. Glennie, et al.
Immunotherapy (2014) Vol. 6, Iss. 11, pp. 1187-1206
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19+tumor cells
Uwe Reusch, Johannes Duell, Kristina Ellwanger, et al.
mAbs (2015) Vol. 7, Iss. 3, pp. 584-604
Open Access | Times Cited: 121
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
Keisuke Watanabe, Angela M. Gomez, Shunichiro Kuramitsu, et al.
Blood Advances (2023) Vol. 7, Iss. 14, pp. 3416-3430
Open Access | Times Cited: 24
CC Chemokine Family Members’ Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury—A Review of Clinical and Experimental Findings
A Ciechanowska, Joanna Mika
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3788-3788
Open Access | Times Cited: 11
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome
Yvette L. Kasamon, Haiyan Chen, R. Angelo de Claro, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 24, pp. 7275-7280
Open Access | Times Cited: 55
Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry
Teizo Asano, Ren Nanamiya, Junko Takei, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2021) Vol. 40, Iss. 3, pp. 107-112
Closed Access | Times Cited: 52
C3Mab-3: A Monoclonal Antibody for Mouse CC Chemokine Receptor 3 for Flow Cytometry
Teizo Asano, Hiroyuki Suzuki, Tomohiro Tanaka, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2022) Vol. 41, Iss. 2, pp. 74-79
Closed Access | Times Cited: 30
Novel targeted therapies of T cell lymphomas
Katarzyna Iżykowska, Karolina Rassek, Dorota Korsak, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 49
CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
Joanna Bogacka, Katarzyna Pawlik, Katarzyna Ciapała, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15638-15638
Open Access | Times Cited: 26
Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain
Katarzyna Pawlik, Joanna Mika
Molecules (2023) Vol. 28, Iss. 15, pp. 5766-5766
Open Access | Times Cited: 16
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Esther Wei Yin Chang, Ya Hwee Tan, Jason Yongsheng Chan
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections
Ryoko Nagao, Yara Yukie Kikuti, Joaquim Carreras, et al.
The American Journal of Surgical Pathology (2016) Vol. 40, Iss. 8, pp. 1041-1050
Closed Access | Times Cited: 45
Novel anti-EPHA2 antibody, DS-8895a for cancer treatment
Jun Hasegawa, Mayumi Sue, Michiko Yamato, et al.
Cancer Biology & Therapy (2016) Vol. 17, Iss. 11, pp. 1158-1167
Open Access | Times Cited: 39
Fabrication of electrochemical immunosensor based on acid-substituted poly(pyrrole) polymer modified disposable ITO electrode for sensitive detection of CCR4 cancer biomarker in human serum
Elif Burcu Aydın, Muhammet Aydın, Mustafa Kemal Sezgintürk
Talanta (2020) Vol. 222, pp. 121487-121487
Closed Access | Times Cited: 36
In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants
Vally Kommineni, Matthew Markert, Zhongjie Ren, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 1, pp. 194-194
Open Access | Times Cited: 32
Safety and efficacy profile of mogamulizumab (Poteligeo) in the treatment of cancers: an update evidence from 14 studies
Ting Zhang, Jing Sun, Jinying Li, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
Caiqin Xie, Xian Li, Hui Zeng, et al.
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors
Kaoru Fujikawa, Takuro Saito, Koji Kurose, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291772-e0291772
Open Access | Times Cited: 8
Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma
Daniel Ren Yi Yap, Jing Quan Lim, Dachuan Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Advances in CAR-T-cell therapy in T-cell malignancies
Rubing Zheng, Xiaojian Zhu, Yi Xiao
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges
Christian Berg, Mette M. Rosenkilde
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome
Jenna Janiga, Jonathan Kentley, Chadi Nabhan, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2018) Vol. 59, Iss. 3, pp. 562-577
Closed Access | Times Cited: 15
Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma
David M. Weiner, Supriya Rastogi, Daniel J. Lewis, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 4
Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
Enrica Marchi, Alexander G. Raufi, Owen A. O’Connor
Hematology/Oncology Clinics of North America (2017) Vol. 31, Iss. 2, pp. 359-375
Closed Access | Times Cited: 12
Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy- free Era
Pavel Klener, Tomáš Etrych, Pavel Klener
Current Medicinal Chemistry (2017) Vol. 26, Iss. 6, pp. 1002-1018
Closed Access | Times Cited: 12
Insight into structural properties of viral G protein‐coupled receptors and their role in the viral infection: IUPHAR Review 41
Naotaka Tsutsumi, Dagmar Fæster Kildedal, Olivia Kramer Hansen, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top